Lasers for medical, life sciences, and high value-add scientific applications
Modulight designs and manufactures lasers for medical applications, including cancer treatments (Oncology), and eye diseases treatment (Ophthalmology). Other important field are high value-add applications: Flow Cytometry, Quantum Computing, and Digital Press.
Trusted Worldwide for Clinical and Scientific Innovation
Modulight is an exclusive supplier to 10+ pharmas, other Fortune 500 companies & well-known cancer centers.
25 years track record of manufacturing lasers and optics from UV wavelengths to beyond 3000 nm.
Fully vertically integrated fab provides supply chain security, and innovative, tailorable products.
Explore Our Core Application Fields
Modulight’s lasers are trusted worldwide in cancer treatments, ophthalmology, fluorescence endoscopy, and life sciences.
With a state-of-the-art, vertically integrated foundry, Modulight can tailor solutions at the semiconductor level, delivering capabilities that surpass standard off-the-shelf technology. From Proof of Concept (PoC) to full-scale production, Modulight is your partner every step of the way.
Oncology
Advanced Photoimmunotherapy (PIT) and Photodynamic Therapy (PDT) lasers optimized for targeted cancer treatment. Precise, controllable light delivery for in‑depth tumor therapy.
Ophthalmology
Clinically proven laser platforms designed for retinal and other ophthalmic treatments, such as of Choroidal neovascularization in Age-related macular deganeration (AMD).
Flow Cytometry
High‑precision lasers for Flow Cytometry applications: automating cell assays, clinical diagnostics, and pharmacological screening in life‑science applications.
Quantum Computing
Quantum applications place strict demands on lasers, particularly regarding stability, low-noise, and narrow linewidth. These applications include laser cooling, magneto-optical trapping, and atom photoionization.
Products in spotlight:
ML6710i
ML6710i is a medical laser device for ophthalmology. It’s specifically designed for retinal PDT treatments. The laser is controlled intuitively from iPad app, and it’s very easy to use. Most popular option is to get the laser with the ophthalmic treatment station, allowing always a dedicated PDT laser station ready for patients.
ML7710
ML7710 is the most versatile multichannel & multi-indication laser in the world. The treatment flow has been optimized and it can be further customized to specific needs. ML7710 supports all known photosensitizers. As the only true medical laser platform, it also boasts unmatched security for the investment.
ML8500
ML8500 is a fully automated biomedical illumination system for well plate and petri dish samples. ML8500 has up to six built-in lasers. Cloud-based composition of illumination programs can be done remotely which enables effective research work. ML8500 keeps sample plates within a specified temperature and CO2 range.
Upcoming Events
Latest news and articles
This month we are highlighting exciting findings by S. Takao et al. from Hisataka Kobayashi’s lab at the National Cancer Institute, NIH. Published in Cancer Letters, the study shows that near-infrared photoimmunotherapy can destroy cancer cells by targeting intercellular adhesion molecule-1.
Published in: Cytometry Part B: Clinical Cytometry Authors: Alice Yue, Ryan R. Brinkman, Veronica Nash, Fabian Junker, Goce Bogdanoski, Anagha Divekar, Aaron Tyznik, Josef Spidlen, Wolfgang Kern, Jordi Petriz, Kaska Wloka, Kamila Czechowska
Published in journal Cancer Medicine, the study shows that the therapeutic effect of photoimmunotherapy is highly dependent on the used light irradiation conditions. Application of the ML7710 medical laser at different durations and powers resulted in highest anti-tumor effect with increased light dose but lowering fluence rate below what is currently used in clinic.
Published in: Cancer Immunology, Immunotherapy Authors: Motofumi Suzuki, Aki Furusawa, Hiroshi Yamamoto, Makoto Kano, Miyu Kano, Seiichiro Takao, Shuhei Okuyama, Peter L. Choyke, Hisataka Kobayashi
Laser-sharp research of the month is by Furusawa et al. at Center for Cancer Research, National Cancer Institute, USA. The discovery, published in Annals of Medicine, showed the potential of photoimmunotherapy for treating breast cancer. To expand the usefulness of photoimmunotherapy outside the clinically approved head & neck indication, the new therapy targeted epithelial cell adhesion molecule in breast cancer.
Published in: Annals of Medicine Authors: Aki Furusawa ,Seiichiro Takao, Motofumi Suzuki, Makoto Kano, Hiroshi Yamamoto, Miyu Kano, Peter Choyke, Hisataka Kobayashi
The spotlight of the month goes to Andrew Langley et al. at Tufts University, USA, for their impressive work in leveraging photoacoustic imaging for real-time monitoring of phototherapy. Photoacoustic imaging is 3D, non-ionizing and non-invasive imaging method, based on optical absorption that creates pressure waves detected by ultrasound transducer.
Published in: Langmuir Authors: Sumiao Pang, Rebecca J. Johnson, Nikhil Pandey, Anshika Kapur, Pavlos Anastasiadis, Pranjali Kanvinde, Emylee McFarland, Jeffrey A. Winkles, Graeme F. Woodworth, Anthony J. Kim, Huang Chiao Huang
Modulight in social media
Follow us: modulight.corp modulight.inc modulight modulight.inc modulight